Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Increased
Reduced
Net increased
Funds Holding
4,792
Funds Holding Change
-67
Funds Holding Growth
-1%
Value
$1.36T
Holding in Top 10
1,500
Top 10 Change
-109
Top 10 Growth
-7%
Value Growth
-9%
New
130
Increased
2,108
Reduced
2,169
Closed
135
Capital Inflow
$35.5B
Capital Outflow
$38.8B
Net Capital Flow
-$3.35B
Capital Flow Change
-$25.8B
Calls
$20.1B
Puts
$16.3B
Net Calls
+$3.77B
Put/Call Ratio
0.81